⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2423602 | 0.73 | — | — | |
| SCHEMBL28879727 | 0.73 | — | — | |
| SCHEMBL295632 | 0.70 | EHMT2 (0.48) | — | |
| SCHEMBL15610445 | 0.68 | LMNA (0.36) | — | |
| SCHEMBL1463082 | 0.68 | — | — | |
| SCHEMBL3145825 | 0.68 | GRM5 (0.33) | — | |
| SCHEMBL1119600 | 0.67 | — | — | |
| SCHEMBL1462116 | 0.67 | — | — | |
| SCHEMBL5058342 | 0.67 | RXFP1 (0.41) | — | |
| SCHEMBL237661 | 0.66 | HPGD (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2872474-A2 | ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF | Georgia State University Research Foundation, Inc. (US) | 2015-05-20 | — | — | EP | claimed |
| WO-2014011753-A2 | ANTHRAQUINONE ANALOGS AND METHODS OF MAKING AND USING THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2014-01-16 | — | — | WO | claimed |
| JP-4829449-B2 | — | — | 2011-12-07 | — | — | JP | claimed |
| EP-1027056-B1 | ALPHA-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS | CEPHALON INC (US) | 2009-02-25 | — | — | EP | claimed |
| US-20050059722-A1 | Substituted indazoles, compositions containing them, method of production and use | AVENTIS PHARMA S.A. (FR) | 2005-03-17 | — | — | US | claimed |
| JP-2003508353-A | — | — | 2003-03-04 | — | — | JP | claimed |
| EP-0668860-B1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | UPJOHN CO (US) | 2002-09-11 | — | — | EP | claimed |
| EP-1208097-A2 | SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS | Aventis Pharmaceuticals Inc. (US) | 2002-05-29 | — | — | EP | claimed |
| WO-2001007436-A2 | SUBSTITUTED OXOAZAHETEROCYCLYL COMPOUNDS | AVENTIS PHARMACEUTICALS INC. (US) | 2001-02-01 | — | — | WO | claimed |
| WO-1994011361-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-05-26 | — | — | WO | claimed |
| US-8957097-B2 | Hemi-phorboxazole A derivatives and methods of their use | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-02-17 | — | — | US | disclosed |
| US-20130030027-A1 | HEMI-PHORBOXAZOLE A DERIVATIVES AND METHODS OF THEIR USE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-01-31 | — | — | US | disclosed |
| WO-2011011665-A1 | HEMI-PHORBOXAZOLE A DERIVATIVES AND METHODS OF THEIR USE | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2011-01-27 | — | — | WO | disclosed |
| EP-1027056-B1 | ALPHA-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS | CEPHALON INC (US) | 2009-02-25 | — | — | EP | disclosed |
| US-20060069037-A1 | Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors | CEPHALON, INC. (US) | 2006-03-30 | — | — | US | disclosed |
| US-6096778-A | A PEPTIDE DERIVATIVE USEFUL FOR THE TREATMENT OF MUSCLE WASTING DISORDERS | CEPHALON, INC. (US) | 2000-08-01 | — | — | US | disclosed |
| EP-1021199-A1 | PEPTIDE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON, INC. (US) | 2000-07-26 | — | — | EP | disclosed |
| WO-1999017778-A1 | α-KETOAMIDE MULTICATALYTIC PROTEASE INHIBITORS | CEPHALON INC. (US) | 1999-04-15 | — | — | WO | disclosed |
| WO-1999017790-A1 | PEPTIDE-CONTAINING α-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS | CEPHALON INC. (US) | 1999-04-15 | — | — | WO | disclosed |
| WO-1994011361-A1 | PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES | THE UPJOHN COMPANY (US) | 1994-05-26 | — | — | WO | disclosed |